Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 5/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.60 |
| ▸ | TYR | P14679 | 1/20 | 0.60 |
| ▸ | DAO | P14920 | 1/20 | 0.60 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | MAOB | P27338 | 6/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | CA12 | O43570 | 3/20 | 0.55 |
| ▸ | CA9 | Q16790 | 3/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA3 | P07451 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | CA4 | P22748 | 1/20 | 0.55 |
| ▸ | CA6 | P23280 | 1/20 | 0.55 |
| ▸ | CA5A | P35218 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL428053 | 1.00 | HPGD (0.60) | HPGDSMN1; SMN2TYRDAOAKR1B1 | |
| SCHEMBL29517170 | 0.78 | RAB9A (0.78) | HPGDSMN1; SMN2TYRDAOAKR1B1 | |
| SCHEMBL4632815 | 0.77 | HPGD (0.62) | HPGDSMN1; SMN2TYRDAOAKR1B1 | |
| SCHEMBL3082095 | 0.75 | MAOB (0.63) | HPGDSMN1; SMN2TYRDAOAKR1B1 | |
| SCHEMBL382039 | 0.75 | HPGD (0.60) | HPGDSMN1; SMN2TYRDAOAKR1B1 | |
| 3-Hydroxycoumarin SCHEMBL76090 | 0.75 | HPGD (1.00) | HPGDSMN1; SMN2TYRDAOAKR1B1 | |
| SCHEMBL95179 | 0.75 | SMN1; SMN2 (1.00) | HPGDSMN1; SMN2TYRDAOAKR1B1 | |
| SCHEMBL1871083 | 0.75 | HPGD (0.60) | HPGDSMN1; SMN2TYRDAOAKR1B1 | |
| SCHEMBL9643651 | 0.75 | HPGD (0.60) | HPGDSMN1; SMN2TYRDAOAKR1B1 | |
| SCHEMBL30023 | 0.75 | HPGD (0.60) | HPGDSMN1; SMN2TYRDAOAKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11858887-B2 | Linker compounds, methods of producing the same and uses thereof | SHENKAR COLLEGE OF ENGINEERING AND DESIGN (IL) | 2024-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11858887-B2 | Linker compounds, methods of producing the same and uses thereof | PAICS, CA1, ECPAS | HPGD 1085/4885SMN1; SMN2 2962/4885TYR 2987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.